Sign in

Type 2 diabetes: open trials in China

189 open trials have a site in China. Registry data; only the trial team decides who can take part.

  • NCT07580638

    Chiglitazar Added to SGLT-2 Inhibitors for Type 2 Diabetes

    Research · Chipscreen Biosciences, Ltd.

    Beijing Hospital, Beijing · West China Hospital of Sichuan University, Chengdu

    Registry updated 2026-11-05

  • NCT07670416

    A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes

    Trial Treatment · Phase 3 · Hoffmann-La Roche

    Peking University People's Hospital, Beijing · The Second Hospital of Jilin University, Changchun · The Second Affiliated Hospital Of Anhui Medical University, Hefei · The Fourth Affiliated Hospital of Harbin Medical University, Herbin · Huai'an First People's Hospital, Huai'an · Huzhou Central Hospital, Huzhou · Jinan Central Hospital, Jinan · Hebei Petro China Central Hospital, Langfang · Luoyang Third People's Hospital, Luoyang · The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing · The First Affiliated Hospital of Ningbo University(Ningbo First Hospital), Ningbo · Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai · Shanghai Fifth People's Hospital Affiliated to Fudan University, Shanghai · Shanghai East Hospital, Shanghai · Shanghai Tenth People's Hospital, Shanghai · The People's Hospital of Liaoning Province, Shenyang · Shenyang Fifth People Hospital, Shenyang · Hebei Medical University - The Second Hospital, Shijiazhuang · Yan'an University Xianyang Hospital, Xianyang · The Second Affiliated Hospital of Zhengzhou University, Zhengzhou · Zibo Municipal Hospital, Zibo

    Registry updated 2026-11-05

  • NCT07920640

    Fuling Yunhua Granules and Dihuang Baoyuan Granules in Adults With Type 2 Diabetes and Poor Glycemic Control Despite Lifestyle Intervention

    Trial Treatment · Phase 2 · Beijing Supreme Life Pharmaceutical Technology Co., Ltd.

    Peking University People's Hospital, Beijing

    Registry updated 2026-11-05

  • NCT07282600

    A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Beijing Pinggu District Hospital, Beijing · Peking University People's Hospital, Beijing · Luhe Hospital, Beijing · Sichuan Provincial People's Hospital, Chengdu · The Second Affiliated Hospital Chongqing Medical University, Chongqing · Zhujiang Hospital, Guangzhou · The Second People's Hospital of Hefei, Hefei · Jinan Central Hospital, Jinan · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi · Jiangxi Provincial People's Hospital, Nanchang · Jiangsu Province Official Hospital, Nanjing · Nanjing First Hospital, Nanjing · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Jiading District Central Hospital, Shanghai · The Second Hospital of Tianjin Medical University, Tianjin · Zigong First People's Hospital, Zigong

    Registry updated 2026-11-04

  • NCT07392190

    A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

    Trial Treatment · Phase 3 · Eli Lilly and Company

    The First Hospital of Jilin University, Changchun · The Second Hospital of Jilin University, Changchun · The Second Xiangya Hospital of Central South University, Changsha · West China Hospital,Sichuan University, Chengdu · Sichuan Provincial People's Hospital, Chengdu · 2nd Affiliated Hospital Chongqing Medical Universi, Chongqing · Zhujiang Hospital, Guangzhou · The Affiliated Hospital of Guizhou Medical University, Guiyang · The Second People's Hospital of Hefei, Hefei · Huzhou Central Hospital, Huzhou · Jinan Central Hospital, Jinan · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi · Affiliated Hospital of Luzhou Medical College, Luzhou · Jiangxi Provincial People's Hospital, Nanchang · Nanjing First Hospital, Nanjing · Zhongda Hospital Southeast University, Nanjing · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Ningbo First Hospital, Ningbo · Zhongshan Hospital,Fudan University, Shanghai · The 2nd Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou · The Central Hospital of Wuhan, Wuhan · Xianyang Hospital of Yan'an University, Xianyang

    Registry updated 2026-11-04

  • NCT07697391

    AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes

    Trial Treatment · Phase 4 · The First Affiliated Hospital of Anhui Medical University

    The First Affiliated Hospital of Chongqing Medical University, Chongqing · The First Affiliated Hospital of Anhui Medical University, Hefei · The Second Affiliated Hospital Of Anhui Medical University, Hefei · First Hospital of Shanxi Medical University, Taiyuan · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

    Registry updated 2026-11-04

  • NCT07881458

    A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

    Trial Treatment · Phase 3 · Eli Lilly and Company

    The Second Hospital of Jilin University, Changchun · Jinan Central Hospital, Jinan · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Ningbo First Hospital, Ningbo · The First Hospital of Hebei Medical University, Shijiazhuang · Tianjin Medical University Zhu Xianyi Memorial Hospital, Tianjin

    Registry updated 2026-11-04

  • NCT07881432

    A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Peking University First Hospital, Beijing · Peking University People's Hospital, Beijing · Luhe Hospital, Beijing · The Second Hospital of Jilin University, Changchun · The Third Xiangya Hospital of Central South University, Changsha · Sichuan Provincial People's Hospital, Chengdu · 2nd Affiliated Hospital Chongqing Medical Universi, Chongqing · Zhujiang Hospital, Guangzhou · The First Affiliated Hospital of Jinan University, Guangzhou · The Second People's Hospital of Hefei, Hefei · Jinan Central Hospital, Jinan · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang · Affiliated Hospital of Luzhou Medical College, Luzhou · Jiangxi Provincial People's Hospital, Nanchang · Nanjing Medical University - Nanjing Jiangning Hospital, Nanjing · Nanjing First Hospital, Nanjing · Jiangsu Province Official Hospital, Nanjing · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · The First Affiliated Hospital of Nanyang Medical College, Nanyang · Ningbo First Hospital, Ningbo · The First Hospital of Qinhuangdao, Qinhuangdao Shi · Jiading District Central Hospital, Shanghai · The First Hospital of Hebei Medical University, Shijiazhuang · The First Affiliated Hospital of Soochow University, Suzhou · Xianyang Hospital of Yan'an University, Xianyang

    Registry updated 2026-11-03

  • NCT07900633

    A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

    Trial Treatment · Phase 3 · Eli Lilly and Company

    Xuanwu Hospital, Capital Medical University, Beijing · Peking University Third Hospital, Beijing · West China Hospital,Sichuan University, Chengdu · Sichuan Provincial People's Hospital, Chengdu · Zhujiang Hospital, Guangzhou · The Second Affiliated Hospital of Zhejiang University School of Medicine - Jiefanglu Campus, Hangzhou · The First Hospital of Harbin Medical University, Harbin · Jinan Central Hospital, Jinan · Panjin Liaoyou Baoshihua Hospital, Liaoyou · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang Shi · Zhongda Hospital Southeast University, Nanjing · Nanjing First Hospital, Nanjing · Jiading District Central Hospital, Shanghai · Shanghai Putuo District Center Hospital, Shanghai · The Third Hospital of Hebei Medical University, Shijiazhuang · Hebei General Hospital, Shijiazhuang · Tianjin Medical University General Hospital, Tianjin · The 2nd Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou · The Affiliated Hospital of Xuzhou Medical College, Xuzhou · The Second People's Hospital of Yibin, Yibin · Zigong First People's Hospital, Zigong

    Registry updated 2026-11-03

  • NCT07913061

    A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin

    Trial Treatment · Phase 3 · Jiangsu HengRui Medicine Co., Ltd.

    Zhongshan Hospital Affiliated to Fudan University, Shanghai · The Third Affiliated Hospital of Sun Yat-sen University, Shenzhen

    Registry updated 2026-11-03

  • NCT07495956

    cfMSC Therapy for Diabetes

    Trial Treatment · Phase 1/2 · Shenzhen Geno-Immune Medical Institute

    Shenzhen Geno-immune Medical Institute, Shenzhen

    Registry updated 2026-11-02

  • NCT07662109

    A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

    Trial Treatment · Phase 3 · AstraZeneca

    Baotou · Beijing · Changde · Changsha · Changzhou · Chengdu · Chenzhou · Chifeng · Hangzhou · Hefei · Huai'an · Jinan · Jincheng · Jining · Jinzhou Shi · Kaifeng · Langfang · Liangyugang · Luoyang · Meihekou · Nanjing · Nantong · Nanyang · Pinggu · Pingxiang · Sanya · Shanghai · Shantou · Shenyang · Shijiazhuang · Tianjin · Wuhan · Wuhu · Xi'an · Xiangyang · Xianyang · Xuzhou · Yan’an · Yueyang · Zhumadian · Zibo

    Registry updated 2026-10-30

  • NCT07784725

    A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

    Trial Treatment · Phase 3 · AstraZeneca

    Beijing · Cangzhou · Changchun · Changsha · Chengdu · Danyang · Ganzhou · Guiyang · Hengshui · Huizhou · Lanzhou · Panjin · Qiqihar · Shanghai · Suzhou · Xiamen · Xianyang · Zigong

    Registry updated 2026-10-30

  • NCT07907536

    Acupuncture Plus Mecobalamin for Diabetic Cardiac Autonomic Neuropathy

    Trial Treatment · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing

    Registry updated 2026-10-30

  • NCT07064473

    EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

    Trial Treatment · Phase 3 · Boehringer Ingelheim

    Baotou Central Hospital, Baotou · Peking University Third Hospital, Beijing · China-Japan Friendship Hospital, Beijing · Xuanwu Hospital, Capital Medical University, Beijing · Jilin Province People's Hospital, Changchun · China-Japan Union Hospital of JiLin University, Changchun · Changsha Central Hospital, Changsha · The Third Xiangya Hospital of Central South University, Changsha · The Second Xiangya Hospital of Central South University, Changsha · The Third Hospital of Changsha, Changsha · Changzhou Second People's Hospital, Changzhou · Sichuan Provincial People's Hospital, Chengdu · West China Hospital,Sichuan University, Chengdu · Second Affiliated Hospital Chongqing Medical University, Chongqing · Center Hospital of Dalian, Dalian · The First Affiliated Hospital of Fujian Medical University, Fuzhou · Nanfang Hosptial, Guangzhou · The Affiliated Panyu Central Hospital of Guangzhou Medical University, Guangzhou · The Affiliated Hospital of Guizhou Medical University, Guiyang · Hainan General Hospital, Haikou · Zhejiang Province People's Hospital, Hangzhou · The First Affiliated Hospital of Harbin Medical University, Harbin · Anhui Provincial Hospital, Hefei · Huizhou Central People's Hospital, Huizhou · Jiangmen Central Hospital, Jiangmen · Center Hospital of Jinan, Jinan · Jining No. 1 People's Hospital., Jining · Affiliated Hospital of Jining Medical University, Jining · The First Affiliated Hospital of Jinzhou Medical University, Jinzhou · Lanzhou University Second Hospital, Lanzhou · Lishui Municipal Central Hospital, Lishui · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · Luoyang Third People's Hospital, Luoyang · University Hospital_Macau University of Science and Technology, Macau · The Second Affiliated Hospital to Nanchang University, Nanchang · Nanchang People's Hospital, Nanchang · Zhongda Hospital Southeast University, Nanjing · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Nanjing Drum Tower hospital, Nanjing · The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning · Affiliated Hospital of Nantong University, Nantong · Nanyang Second General Hospital, Nanyang · The First Affiliated Hospital of Ningbo University, Ningbo · Pingxiang People's Hospital, Pingxiang · First Hospital of Qinhuangdao, Qinhuangdao · Shanghai East Hospital, Shanghai · Centre Hospital of Putuo District, Shanghai, Shanghai · Shanghai General Hospital, Shanghai · People's Hospital of Liaoning Province, Shenyang · Siping Central People's Hospital, Siping · The First Affiliated Hospital of Soochow University, Suzhou · Tianjin Union Medical Center (Nankai University Affiliated Hospital), Tianjin · The Fourth Central Hospital of Tianjin, Tianjin · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · Hubei Province Zhongshan Hospital, Wuhan · Renmin Hospital of Wuhan University, Wuhan · Xiamen Cardiovascular Hospital Xiamen University, Xiamen · Shaanxi provincial people's hospital, Xi'an · Xiangyang Central Hospital, Xiangyang · Xianyang Hospital of Yan'an University, Xianyang · The People's Hospital Of Xuancheng City, Xuancheng · The Affiliated Hospital of Xuzhou Medical College, Xuzhou · General Hospital of Ningxia Medical University, Yinchuan · Affiliated Hospital of Jiangsu University, Zhenjiang · Zibo Municipal Hospital, Zibo

    Registry updated 2026-10-28

  • NCT07784270

    A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

    Trial Treatment · Phase 3 · AstraZeneca

    Beijing · Cangzhou · Changchun · Chengdu · Danyang · Ganzhou · Guangzhou · Huizhou · Huzhou · Lanzhou · Nanjing · Panjin · Suzhou · Xianyang

    Registry updated 2026-10-28

  • NCT07900438

    A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China

    Trial Treatment · Phase 4 · Novo Nordisk A/S

    The People's Hospital of Anyang City/ TGE Center Hospital of Anyang City-Nephrology, Anyang · The First Affiliated Hospital of Baotou Medical College-Nephrology, Baotou · Peking University First Hospital-Nephrology, Beijing · Beijing Friendship Hospital, Capital Medical University-Nephrology, Beijing · Beijing Anzhen Hospital, Capital Medical University-Nephrology, Beijing · The Second Norman Bethune Hospital of Jilin University-Nephrology, Changchun · Changzhou No.2 People's Hospital-Nephrology, Changzhou · Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital; Affiliated Hospital of UESTC-Nephrology, Chengdu · Central Hospital of Dalian University of Technology (Dalian Municipal Central Hospital) -Nephrology, Dalian · Fu Yang People's Hospital-Nephrology, Fuyang · Huizhou Central People's Hospital-Endocrinology, Huizhou · Jinan Central Hospital-General Medicine, Jinan · The Second Hospital & Clinical Medical School, Lanzhou University-Nephrology, Lanzhou · Taizhou Hospital of Zhejiang Province-Nephrology, Linhai · The Second Affiliated Hospital of Nanjing Medical University-Endocrinology, Nanjing · Ningbo No. 2 Hospital-Nephrology, Ningbo · Panjin Liaoyou Gemflower Hospital-Nephrology, Panjin · Pingxiang People's Hospital-Endocrinology, Pingxiang · Shanghai General Hospital-Nephrology, Shanghai · The Second Affiliated Hospital of Shantou University Medical College-Nephrology, Shantou · The Second Hospital of Hebei Medical University-Nephrology, Shijiazhuang · Siping City Central People's Hospital-Nephrology, Siping · Qinghai Provincial People's Hospital-Endocrinology, Xining · The Second People's Hospital of Yibin-Department of Nephrology, Yibin · Yichang Central People's Hospital-Nephrology, Yichang · The Affiliated Hospital of Jiangsu University-Endocrinology, Zhenjiang

    Registry updated 2026-10-28

  • NCT07584330

    AI-Driven Metabolic Cohort in Overweight/Obese Chinese Adults

    Research · Zhujiang Hospital

    Zhujiang Hospital, Guangzhou

    Registry updated 2026-10-27

  • NCT07662213

    A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

    Trial Treatment · Phase 3 · AstraZeneca

    Changsha · Hefei · Huai'an · Langfang · Liangyugang · Luoyang · Nanjing · Nanyang · Pinggu · Pingxiang · Shijiazhuang · Tianjin · Yueyang

    Registry updated 2026-10-22

  • NCT07888855

    Registry updated 2026-10-22

  • NCT07884903

    Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity Risks

    Research · Shanxi Bethune Hospital

    Department of Endocrinology, Shanxi Bethune Hospital, Taiyuan

    Registry updated 2026-10-21

  • NCT07885904

    Registry updated 2026-10-21

  • NCT07351045

    A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

    Trial Treatment · Phase 3 · Hoffmann-La Roche

    Beijing Pinggu Hospital, Beijing · Peking University People's Hospital, Beijing · The First Hospital of Jilin University, Changchun · The Second People's Hospital of Hefei, Hefei · The Fourth Affiliated Hospital of Harbin Medical University, Herbin · Huizhou Central People's Hospital, Huizhou · Jinan Central Hospital, Jinan · Hebei Petro China Central Hospital, Langfang · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · Pingxiang People's Hospital, Pingxiang · Shanghai Pudong New Area People's Hospital, Shanghai · The First Affiliated Hospital of Soochow University, Suzhou · Yan'an University Xianyang Hospital, Xianyang · Affiliated Hospital of Jiangsu University, Zhenjiang

    Registry updated 2026-10-13

  • NCT07351058

    A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

    Trial Treatment · Phase 3 · Hoffmann-La Roche

    Peking University People's Hospital, Beijing · Beijing Pinggu Hospital, Beijing · Cangzhou People's Hospital, Cangzhou · The First Hospital of Jilin University, Changchun · The Second People's Hospital of Hefei, Hefei · The Fourth Affiliated Hospital of Harbin Medical University, Herbin · Huizhou Central People's Hospital, Huizhou · Jinan Central Hospital, Jinan · Huai He Hospital of Henan University, Kaifeng · Hebei Petro China Central Hospital, Langfang · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing · The Second Affiliated Hospital of Nanjing Medical University, Nanjing · The First Affiliated Hospital of Ningbo University, Ningbo · Pingxiang People's Hospital, Pingxiang · Shanghai Pudong New Area People's Hospital, Shanghai · Shanghai Fifth People's Hospital Affiliated to Fudan University, Shanghai · Siping Central People's Hospital, Siping · The First Affiliated Hospital of Soochow University, Suzhou · Wuxi People's Hospital, Wuxi · The First Affiliated Hospital of Xi'an Medical University, Xi'an · Yan'an University Xianyang Hospital, Xianyang · The affiliated hospital of xuzhou medical university, Xuzhou · Yueyang Central Hospital, Yueyang · Affiliated Hospital of Jiangsu University, Zhenjiang

    Registry updated 2026-10-13

  • NCT07667803

    A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

    Trial Treatment · Phase 3 · AstraZeneca

    Binzhou · Chengdu · Deyang · Ganzhou · Guangzhou · Haikou · Hangzhou · Huaian · Huzhou · Jinan · Jinzhou · Kunming · Lanzhou · Linhai · Liuzhou · Luoyang · Nanchang · Nanjing · Nantong · Ningbo · Panjin · Pingxiang · Qingdao · Shanghai · Shenyang · Shenzhen · Siping · Suining · Suzhou · Ürümqi · Wanzhou · Wenzhou · Wuhan · Wuxi · Xiangyang · Xuancheng · Yibin · Yichang · Zhengzhou · Zhenjiang · Zunyi

    Registry updated 2026-10-13

All Type 2 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Type 2 diabetes trials in China – Frontlight Research